Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors

Drug and Alcohol Dependence

Volumn 122, Issue 3, 2012, Pages 220-227

  Harrell, P T ^a   Mancha, B E ^a   Petras, H ^b   Trenz, R C ^a   Latimer, W W ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JBS International Inc   (United States)

Author keywords

Cocaine; Heroin; HIV AIDS; Injection; Polydrug; Sex trade

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; CONTROLLED STUDY; CRACK HEROIN USER; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG USE; ETHNIC GROUP; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; NASAL HEROIN USER; PATIENT CODING; POLYSUBSTANCE USER; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX; SUBSTANCE ABUSE; UNITED STATES;

ADULT; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; NEEDLE SHARING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR;

HEPATITIS C VIRUS;

EID: 84859629566     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.10.001     Document Type: Article

References (95)

1. Agrawal A., Lynskey M.T., Madden P.A., Bucholz K.K., Heath A.C. A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2007, 102:94-104.
2. Bandeen-Roche K., Miglioretti D.L., Zeger S.L., Rathouz P.J. Latent variable regression for multiple discrete outcomes. J. Am. Stat. Assoc. 1997, 92:1375-1386.
3. Boyer C.B., Shafer M., Wibbelsman C.J., Seeberg D., Teitle E., Lovell N. Associations of sociodemographic, psychosocial, and behavioral factors with sexual risk and sexually transmitted diseases in teen clinic patients. J. Adolesc. Health 2000, 27:102-111.
4. Boyer C.B., Shafer M.A., Teitle E., Wibbelsman C.J., Seeberg D., Schachter J. Sexually transmitted diseases in a health maintenance organization teen clinic: associations of race, partner's age, and marijuana use. Arch. Pediatr. Adolesc. Med. 1999, 153:838-844.
5. Broz D., Ouellet L.J. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend 2008, 94:221-233.
6. Buchacz K., McFarland W., Hernandez M., Klausner J.D., Page-Shafer K., Padian N., Molitor F., Ruiz J.D., Bolan G., Morrow S., Katz M.H. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California, The Young Women's Survey. Team Sex Transm. Dis. 2000, 27:393-400.
7. Cartwright W.S. Cocaine medications, cocaine consumption and societal costs. Pharmacoeconomics 2000, 18:405-413.
8. Castor D., Pilowsky D.J., Hadden B., Fuller C., Ompad D.C., de Leon C.L., Neils G., Hoepner L., Andrews H.F., Latkin C., Hoover D.R. Sexual risk reduction among non-injection drug users: report of a randomized controlled trial. Aids Care Psychol. Socio Med. Aspects AIDS/HIV 2010, 22:62-70.
9. CDC Estimates of New HIV Infections in the United States. CDC Fact Sheet 2008, Center for Disease Control, Atlanta, pp. 1-6.
10. Chen C.Y., Anthony J.C. Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine. Psychopharmacology (Berl.) 2004, 172:78-86.
11. Chitwood D.D., Comerford M., Sanchez J. Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. J. Psychoactive Drugs 2003, 35:445-453.
12. Clark P.A., Fadus M. Federal funding for needle exchange programs. Med. Sci. Monit. 2010, 16:1-13.
13. Comer S.D., Collins E.D., MacArthur R.B., Fischman M.W. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 1999, 143:327-338.
14. Courtwright D. Dark Paradise: Opiate Addiction in America Before 1940 1982, Harvard University Press, Cambridge.
15. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51:253-263.
16. Drumright L.N., Colfax G.N. HIV risk and prevention for non-injection substance users. HIV Prevention: A Comprehensive Approach 2009, Academic Press, Burlington, MA, pp. 340-375. K.H. Mayer, H. Pizer (Eds.).
17. Ferreira R.C., Rodrigues F.P., Teles S.A., Lopes C.L., Motta-Castro A.R., Novais A.C., Souto F.J., Martins R.M. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users. J. Med. Virol. 2009, 81:602-609.
18. Gossop M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br. J. Addict. 1992, 87:1527-1536.
19. Gossop M., Griffiths P., Powis B., Strang J. Cocaine: patterns of use, route of administration, and severity of dependence. Br. J. Psychiatry 1994, 164:660-664.
20. Gossop M., Griffiths P., Powis B., Williamson S., Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ 1996, 313:402-410.
21. Green K.M., Doherty E.E., Reisinger H.S., Chilcoat H.D., Ensminger M. Social integration in young adulthood and the subsequent onset of substance use and disorders among a community population of urban African Americans. Addiction 2010, 105:484-493.
22. Grella C.E., Karno M.P., Warda U.S., Niv N., Moore A.A. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict. Behav. 2009, 34:498-504.
23. Haas A.L., Sorensen J.L., Hall S.M., Lin C., Delucchi K., Sporer K., Chen T. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. Am. J. Addict. 2008, 17:65-69.
24. Harrell P., Trenz R., Zur J., Mancha B., Latimer W. Cigarette Smoking, Illicit Drug Use, and Routes of Administration Among Heroin and Cocaine Users 2011, Society for Prevention Research Conference, Washington, DC.
25. Hickman M., Hope V., Brady T., Madden P., Jones S., Honor S., Holloway G., Ncube F., Parry J. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J. Viral Hepat. 2007, 14:645-652.
26. Hogan J.W., Roy J., Korkontzelou C. Handling drop-out in longitudinal studies. Stat. Med. 2004, 23:1455-1497.
27. Hser Y.I., McCarthy W.J., Anglin M.D. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev. Med. 1994, 23:61-69.
28. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., Melton L.J. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996, 275:1097-1103.
29. Hutton H.E., McCaul M.E., Santora P.B., Erbelding E.J. The relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patients. Alcohol. Clin. Exp. Res. 2008, 32:2008-2015.
30. Jenness S.M., Kobrak P., Wendel T., Neaigus A., Murrill C.S., Hagan H. Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. J. Urban Health 2011, 88:329-341.
31. Johnston L.D., O'Malley P.M., Bachman J.G. Monitoring the Future: National Survey Results on Drug Use, 1975-2001, Secondary School Students (NIH Publication No. 02-5106), vol. 1 2002, National Institute on Drug Abuse, Bethesda, MD.
32. Jurgens R., Ball A., Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect. Dis. 2009, 9:57-66.
33. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 1985, 142:1259-1264.
34. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 1997, 4:231-244.
35. Kokkevi A., Stefanis N., Anastasopoulou E., Kostogianni C. Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention. Addict. Behav. 1998, 23:841-853.
36. Kuo I., Greenberg A.E., Magnus M., Phillips G., Rawls A., Peterson J., Hamilton F., West-Ojo T., Hader S. High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC. Drug Alcohol Depend 2011, 117:139-144.
37. Kuo I., Sherman S.G., Thomas D.L., Strathdee S.A. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend. 2004, 73:69-78.
38. Kuramoto S.J., Bohnert A.S., Latkin C.A. Understanding subtypes of inner-city drug users with a latent class approach. Drug Alcohol Depend. 2011, 215. 30105.
39. Latkin C.A., Kuramoto S.J., Davey-Rothwell M.A., Tobin K.E. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behav. 2010, 14:1159-1168.
40. Lazarsfeld P., Henry N. Latent Structure Analysis 1968, Houghton Mifflin, New York.
41. Lejuez C.W., Bornovalova M.A., Daughters S.B., Curtin J.J. Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users. Drug Alcohol Depend. 2005, 77:169-175.
42. Leri F., Bruneau J., Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003, 98:7-22.
43. Leri F., Stewart J., Tremblay A., Bruneau J. Heroin and cocaine co-use in a group of injection drug users in Montreal. J. Psychiatry Neurosci. 2004, 29:40-47.
44. Lindesmith A. Addiction and Opiates 1947, Aldine Publishing Company, Chicago.
45. Lo Y., Mendell N., Rubin D. Testing the number of components in a normal mixture. Biometrika 2001, 88:767-778.
46. Lubke G.H., Muthen B. Investigating population heterogeneity with factor mixture models. Psychol. Methods 2005, 10:21-39.
47. Magura S., Kang S.Y., Shapiro J.L. Outcomes of intensive AIDS education for male adolescent drug users in jail. J. Adolesc. Health 1994, 15:457-463.
48. Mark T.L., Woody G.E., Juday T., Kleber H.D. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 2001, 61:195-206.
49. Marshall M.M., McCormack M.C., Kirk G.D. Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ. Preven. 2009, 21:28-39.
50. Martins S.S., Carlson R.G., Alexandre P.K., Falck R.S. Perceived risk associated with ecstasy use: a latent class approach. Addict. Behav. 2011, 36:551-554.
51. Masyn K.E., Henderson C.E., Greenbaum P.E. Exploring the latent structures of psychological constructs in social development using the dimensional-categorical spectrum. Soc. Dev. 2010, 19:470-493.
52. McCoy C.B., Lai S., Metsch L.R., Messiah S.E., Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann. Epidemiol. 2004, 14:535-542.
53. McCutcheon A.L. Latent Class Analysis 1987, Sage Publications, Thousand Oaks, CA.
54. McKirnan D.J., Ostrow D.G., Hope B. Sex, drugs and escape: a psychological model of HIV-risk sexual behaviours. AIDS Care 1996, 8:655-669.
55. McLachlan G., Peel D. Finite Mixture Models 2000, John Wiley, New York.
56. Mehta S.H., Astemborski J., Kirk G.D., Strathdee S.A., Nelson K.E., Vlahov D., Thomas D.L. Changes in blood-borne infection risk among injection drug users. J. Infect. Dis. 2011, 203:587-594.
57. Miller M., Korves C.T., Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. Aids Care-Psychol. Socio-Med. Aspects of AIDS/HIV 2007, 19:858-865.
58. Miller M., Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care 2002, 14:801-813.
59. Mitchell M., Severtson S., Graham C., Floyd L., Latimer W. The moderating influence of cognitive performance on risk awareness to predict HIV/AIDS risk-taking behaviors. Retrovirology 2006, 3:P41.
60. Monga N., Rehm J., Fischer B., Brissette S., Bruneau J., El-Guebaly N., Noel L., Tyndall M., Wild C., Leri F., Fallu J.S., Bahl S. Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend. 2007, 88:1-8.
61. Muthén, B.O., Asparouhov, T., 2007. Wald test of mean equality for potential latent class predictors in mixture modeling. accessed on April 19 2011. http://www.statmodel.com/download/MeanTest1.pdf.
62. Muthén L.K., Muthén B.O. Mplus User's Guide 2010, Muthén and Muthén, Los Angeles, CA. Sixth Edition.
63. Neaigus A., Friedman S.R., Kottiri B.J., Jarlais D.C.D. HIV risk networks and HIV transmission among injecting drug users. Eval. Program Plann. 2001, 24:221-226.
64. Neblett R.C., Davey-Rothwell M., Chander G., Latkin C.A. Social network characteristics and HIV sexual risk behavior among urban african american women. J. Urban Health 2011, 88:54-65.
65. Nelson K.E., Galai N., Safaeian M., Strathdee S.A., Celentano D.D., Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am. J. Epidemiol. 2002, 156:641-653.
66. Nylund K.L., Asparoutiov T., Muthen B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct. Eq. Model. 2007, 14:535-569.
67. Patkar A.A., Batra V., Mannelli P., Evers-Casey S., Vergare M.J., Leone F.T. Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependent patients. Am. J. Addict. 2005, 14:43-53.
68. Patkar A.A., Lundy A., Leone F.T., Weinstein S.P., Gottheil E., Steinberg M. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Subst. Abuse 2002, 23:105-114.
69. Patra J., Fischer B., Maksimowska S., Rehm J. Profiling poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in Canada-a latent class analysis. Addict. Res. Theory 2009, 17:168-185.
70. Petras H., Masyn K. General growth mixture analysis with antecedents and consequences of change. Handbook of Quantitative Criminology 2010, Springer, New York, pp. 69-100. A. Piquero, D. Weisburd (Eds.).
71. Pilowsky D.J., Hoover D., Hadden B., Fuller C., Ompad D.C., Andrews H.F., De Leon C.L., Hoepner L., Xia Q., Latkin C. Impact of social network characteristics on high-risk sexual Behaviors among non-injection drug users. Subst. Use Misuse 2007, 42:1629-1649.
72. Pines H., Koutsky L., Buskin S. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS Behav. 2011, 15:243-251.
73. Raj A., Saitz R., Cheng D.M., Winter M., Samet J.H. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am. J. Drug Alcohol Abuse 2007, 33:169-178.
74. Ramaswamy V., Desarbo W.S., Reibstein D.J., Robinson W.T. An empirical pooling approach for estimating marketing mix elasticities with PIMS Data. Market Sci. 1993, 12:103-124.
75. Reboussin B.A., Anthony J.C. Is there epidemiological evidence to support the idea that a cocaine dependence syndrome emerges soon after onset of cocaine use?. Neuropsychopharmacology 2006, 31:2055-2064.
76. Reboussin B.A., Song E.Y., Shrestha A., Lohman K.K., Wolfson M. A latent class analysis of underage problem drinking: evidence from a community sample of 16-20 year olds. Drug Alcohol Depend. 2006, 83:199-209.
77. Rich J.D., Anderson B.J., Schwartzapfel B., Stein M.D. Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users. Epidemiol. Infect. 2006, 134:478-484.
78. Ross L., Kohler C.L., Grimley D.M., Bellis J. Intention to use condoms among three low-income, urban African American subgroups: cocaine users, noncocaine drug users, and non-drug users. J. Urban Health 2003, 80:147-160.
79. Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD.
80. Schafer J.L., Graham J.W. Missing data: our view of the state of the art. Psychol. Methods 2002, 7:147-177.
81. Scheier L.M., Ben Abdallah A., Inciardi J.A., Copeland J., Cottler L.B. Tri-city study of ecstasy use problems: a latent class analysis. Drug Alcohol Depend. 2008, 98:249-263.
82. Schwartz G. Estimating the dimension of a model. Ann. Stat. 1978, 6:461-464.
83. Severtson S.G., Hedden S.L., Martins S.S., Latimer W.W. Patterns of cognitive impairments among heroin and cocaine users: the association with self-reported learning disabilities and infectious disease. J. Learn. Disabil. 2010.
84. Severtson S.G., Mitchell M.M., Hubert A., Latimer W. The relationship between performance on the Shipley Institute of Living Scale (SILS) and hepatitis C infection among active injection drug users in Baltimore, Maryland. Am. J. Drug Alcohol Abuse 2010, 36:61-65.
85. Lawrence J.S., Crosby R.A., Brasfield T.L., O'Bannon R.E. Reducing STD and HIV risk behavior of substance-dependent adolescents: a randomized controlled trial. J. Consult. Clin. Psychol 2002, 70:1010-1021.
86. Strang J., Bearn J., Farrell M., Finch E., Gossop M., Griffiths P., Marsden J., Wolff K. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev. 1998, 17:197-211.
87. Strang J., Griffiths P., Powis B., Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am. J. Addict. 1999, 8:148-160.
88. Strathdee S.A., Sherman S.G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J. Urban Health 2003, 80:7-14.
89. Sulkowski M.S., Ray S.C., Thomas D.L. Needlestick transmission of hepatitis C. JAMA 2002, 287:2406-2413.
90. Tobin K.E., Kuramoto S.J., Davey-Rothwell M.A., Latkin C.A. The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction 2011, 106:366-375.
91. Vallejo F., Toro C., de la Fuente L., Brugal M.T., Soriano V., Silva T.C., Bravo M.J., Ballesta R., Barrio G. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville. Eur. Addict. Res. 2008, 14:116-124.
92. Wang C.P., Brown C.H., Bandeen-Roche K. Residual diagnostics for growth mixture models: examining the impact of a preventive intervention on multiple trajectories of aggressive behavior. J. Am. Stat. Assoc. 2005, 100:1054-1076.
93. Wechsberg W.M., Luseno W.K., Karg R.S., Young S., Rodman N., Myers B., Parry C.D. Alcohol, cannabis, and methamphetamine use and other risk behaviours among Black and Coloured South African women: a small randomized trial in the Western Cape. Int. J. Drug Policy 2008, 19:130-139.
94. Whitesell N.R., Beals J., Mitchell C.M., Novins D.K., Spicer P., Manson S.M., Team A.-S. Latent class analysis of substance use: comparison of two American Indian reservation populations and a national sample. J. Stud. Alcohol 2006, 67:32.
95. Windle M. The trading of sex for money or drugs, sexually transmitted diseases (STDs), and HIV-related risk behaviors among multisubstance using alcoholic inpatients. Drug Alcohol Depend. 1997, 49:33-38.